Analyzing Longview Acquisition Corp. II (NYSE:LGV) and Beauty Health (NASDAQ:SKIN)

Longview Acquisition Corp. II (NYSE:LGV – Get Rating) and Beauty Health (NASDAQ:SKIN – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

Institutional & Insider Ownership

65.8% of Longview Acquisition Corp. II shares are owned by institutional investors. Comparatively, 72.0% of Beauty Health shares are owned by institutional investors. 34.3% of Beauty Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Longview Acquisition Corp. II has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500. Comparatively, Beauty Health has a beta of 1.67, indicating that its share price is 67% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and price targets for Longview Acquisition Corp. II and Beauty Health, as provided by MarketBeat.

Beauty Health has a consensus price target of $24.44, suggesting a potential upside of 96.66%. Given Beauty Health's higher probable upside, analysts clearly believe Beauty Health is more favorable than Longview Acquisition Corp. II.

Profitability

This table compares Longview Acquisition Corp. II and Beauty Health's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Longview Acquisition Corp. II and Beauty Health's gross revenue, earnings per share and valuation.

Longview Acquisition Corp. II has higher earnings, but lower revenue than Beauty Health.

Summary

Beauty Health beats Longview Acquisition Corp. II on 7 of the 10 factors compared between the two stocks.

About Longview Acquisition Corp. II (Get Rating)

Longview Acquisition Corp. II does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on businesses in the healthcare, industrials, consumer, media, technology, and technology services sector. The company was incorporated in 2020 and is based in New York, New York.

About Beauty Health (Get Rating)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

Receive News & Ratings for Longview Acquisition Corp. II Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Longview Acquisition Corp. II and related companies with MarketBeat.com's FREE daily email newsletter.